- World rank, all time
- #32,309 of 42,892
- Rank in Spain
- #752 of 927
- Research works
- 152 ▲ 121% vs 2013–17
- Citations
- 1.1k 7.4 per fractional work
- Top-10% rate
- 8.4% record average 16.5%
- Open access
- 58% world 28%
What does ViiV Healthcare (Spain) specialise in?
Where its research is concentrated relative to its size: Medicine takes 2.8× the share of its output that it takes of world research.
- MedicineField · 29.2 works2.8×
- Health SciencesDomain · 32.7 works2.6×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.0×. Every wedge is a field page.
- Immunology and Microbiology 7.0×
- Medicine 2.8×
- Health Professions 2.1×
- Economics, Econometrics and Finance 1.8×
- Decision Sciences 1.2×
- Biochemistry, Genetics and Molecular Biology 0.9×
- Agricultural and Biological Sciences 0.8×
- Dentistry 0.8×
- Psychology 0.7×
- Social Sciences 0.7×
- Nursing 0.6×
- Neuroscience 0.6×
- Computer Science 0.4×
- Environmental Science 0.3×
- Business, Management and Accounting 0.2×
- Engineering 0.1×
- Mathematics 0.1×
- Arts and Humanities 0.1×
- Chemistry 0.1×
Which keywords describe research at ViiV Healthcare (Spain)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Antiretroviral Therapy, HIV Infection, Drug Resistance, HIV, Integrase Inhibitors, Nucleoside Analogues, HIV Transmission and Preexposure Prophylaxis.
- Clinical Trials
- Data Mining
- Circus Activities
- Artificial Intelligence
- Pedagogy
- harm reduction
- Treatment
- Health Utility Measures
- Vaccine
- AIDS
- Lipodystrophy
- Insulin Resistance
- Aging
- Quality of Life
- Stigma and Discrimination
- HIV Transmission
- Inflammation
- Integrase Inhibitors
- Drug Resistance
- HIV Infection
- Antiretroviral Therapy
- Epidemiology
- HIV
- Nucleoside Analogues
- Public Health
- Preexposure Prophylaxis
- Immune Response
- Cardiovascular Disease
- Bone Mineral Density
- Myocardial Infarction
- Metabolic Abnormalities
- Antibodies
- Cost-effectiveness Analysis
- Healthcare
- drug use
- Risk Factors
- Antiviral Therapy
- Big Data Analytics
- Complications
- Physical Education
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Antiretroviral Therapy15▲ 168×5 topics
- HIV Infection8▲ 138×2 topics
- Epidemiology6▲ 3.0×31 topics
- Drug Resistance6▲ 35×3 topics
- HIV5▲ 109×4 topics
- Integrase Inhibitors5▲ 411×1 topic
- Nucleoside Analogues5▲ 411×1 topic
- Inflammation4▲ 3.8×10 topics
- Public Health4▲ 5.4×12 topics
- HIV Transmission4▲ 105×2 topics
- Preexposure Prophylaxis4▲ 156×1 topic
- Stigma and Discrimination4▲ 156×1 topic
- Immune Response4▲ 12×4 topics
- Quality of Life4▲ 4.6×13 topics
- Cardiovascular Disease4▲ 5.7×8 topics
- Aging3▲ 11×3 topics
- Bone Mineral Density3▲ 81×3 topics
- Insulin Resistance3▲ 13×3 topics
- Myocardial Infarction3▲ 25×2 topics
- Lipodystrophy3▲ 290×1 topic
- Metabolic Abnormalities3▲ 290×1 topic
- AIDS3▲ 210×1 topic
- Antibodies3▲ 94×1 topic
- Vaccine3▲ 13×2 topics
- Cost-effectiveness Analysis2▲ 32×1 topic
- Health Utility Measures2▲ 32×1 topic
- Healthcare2▲ 2.5×6 topics
- Treatment2▲ 2.3×9 topics
- drug use2▲ 96×1 topic
- harm reduction2▲ 96×1 topic
- Risk Factors1▲ 2.2×7 topics
- Pedagogy1▲ 4.7×2 topics
- Antiviral Therapy1▲ 20×3 topics
- Artificial Intelligence1▲ 1.52×5 topics
- Big Data Analytics1▲ 9.2×2 topics
- Circus Activities1▲ 148×1 topic
- Complications1▲ 4.2×4 topics
- Data Mining1▲ 2.6×2 topics
- Physical Education1▲ 16×1 topic
- Clinical Trials1▲ 2.8×7 topics
Which research topics does ViiV Healthcare (Spain) publish most on?
By volume in 2022–2025: HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV-related health complications and treatments and HIV Research and Treatment.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 HIV/AIDS drug development and treatment Infectious Diseases 5 works
- 2 HIV/AIDS Research and Interventions Infectious Diseases 4 works
- 3 HIV-related health complications and treatments Emergency Medicine 3 works
- 4 HIV Research and Treatment Virology 3 works
- 5 HIV, Drug Use, Sexual Risk Epidemiology 2 works
- 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 7 Physical Education and Gymnastics Education 1 works
- 8 Artificial Intelligence in Healthcare Health Information Management 1 works
- 9 Healthcare Regulation Health Information Management 1 works
- 10 Hepatitis C virus research Hepatology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has ViiV Healthcare (Spain)'s research output changed?
Output in 2018–2022 was 121% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Madrid
- Universidad Complutense de Madrid
- Universidad Autónoma de Madrid
- Universidad Politécnica de Madrid
- Consejo Superior de Investigaciones Científicas
- Universidad Carlos III de Madrid
- Universidad Rey Juan Carlos
- Universidad Nacional de Educación a Distancia
- Hospital Universitario La Paz
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.